ArticleCVIR endovascular2025
Fertility outcomes after uterine artery embolization for symptomatic leiomyomas.
Article in CVIR endovascular, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05271981 (Uterine Artery Embolization For Uterine Pathology), which is not on this map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Uterine Artery Embolization For Uterine Pathology: What Impact On Fertility?
Who cites it
4 citing papers in PubMed.
- The Role of Interventional Radiology in the Diagnosis and Treatment of Gynecological Conditions.Tomography (Ann Arbor, Mich.) · 2026Review
- Ruptured postpartum ovarian artery aneurysm, endovascular limitations and the value of open vascular control.Journal of vascular surgery cases and innovative techniques · 2026Article
- Successful full-term pregnancy after bilateral uterine artery embolization for a large intracavitary submucosal fibroid: A case report.Case reports in women's health · 2026Article
- Uterine artery embolization with or without methotrexate followed by D&C versus D&C alone for cervical pregnancy: a retrospective cohort study.BMC pregnancy and childbirth · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundUterine artery embolization (UAE) is a recognized treatment for symptomatic fibroids, but its impact on fertility remains controversial. This study aimed to assess live birth rates, pregnancy outcomes, and obstetric complications in patients attempting pregnancy after UAE. MATERIALS AND
methodsWe conducted a retrospective monocentric study including women aged 18-45 years treated by UAE for symptomatic fibroids between June 2007 and March 2021. Patients who attempted pregnancy post-procedure were identified and analyzed. The primary outcome was the live birth rate; secondary outcomes included pregnancy rate and obstetric complications. Statistical analyses were performed according to the STROBE guidelines.
resultsAmong 210 included patients, 46 attempted pregnancy (22%). The mean age of this fertility population was 40 years. Thirteen women (28%) began at least one pregnancy after UAE, resulting in 12 births overall in 9 mothers. All live births were delivered via cesarean section, and no fatal obstetric complications occurred in this cohort. The miscarriage rate (23%) and other obstetric outcomes were consistent with general population trends for similar age groups. UAE demonstrated high symptom resolution, with 70% of patients requiring no further interventions for fibroids.
conclusionFertility may be preserved in a subset of women with complex surgical histories or high-risk surgical profiles undergoing UAE for symptomatic fibroids.
trial registrationNCT05271981.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.